Estudo randomizado | Para adultos vivendo com HIV, uma estratégia de tratamento de 4-dias-sim e 3-dias-não é não inferior ao tratamento padrão para manter a supressão viral.

A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial – The Lancet HIV (link para o resumo – $ para o texto completo)

Comentário: Intermittent Treatment Strategy Is Effective for HIV – Consultant360

Comentário no Twitter

New: A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial by Roland Landman and colleagues https://t.co/Tc2Rbo1ISt pic.twitter.com/YTV3XwfELo

— The Lancet HIV (@TheLancetHIV) February 3, 2022

In virologically suppressed people with HIV, randomization to intermittent ART (4 days on, 3 off) was non-inf. to daily dosing. Challenges what I thought about level of adherence needed. Is good adherence only needed during the viremic phase? https://t.co/lM8QZW0C9h

— David Serota (@serotavirus) March 16, 2022